Cargando…

P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales: Nedumannil, Rithin, Batterham, Emily, Wei, Andrew, Bajel, Ashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428938/
http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca
_version_ 1785090590575165440
author Nedumannil, Rithin
Batterham, Emily
Wei, Andrew
Bajel, Ashish
author_facet Nedumannil, Rithin
Batterham, Emily
Wei, Andrew
Bajel, Ashish
author_sort Nedumannil, Rithin
collection PubMed
description
format Online
Article
Text
id pubmed-10428938
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104289382023-08-17 P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA Nedumannil, Rithin Batterham, Emily Wei, Andrew Bajel, Ashish Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428938/ http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Nedumannil, Rithin
Batterham, Emily
Wei, Andrew
Bajel, Ashish
P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title_full P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title_fullStr P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title_full_unstemmed P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title_short P543: CONSECUTIVE DAY DOSING OF HIGH-DOSE CYTARABINE CONSOLIDATION OVER 3 DAYS IS FEASIBLE IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA
title_sort p543: consecutive day dosing of high-dose cytarabine consolidation over 3 days is feasible in older patients with acute myeloid leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428938/
http://dx.doi.org/10.1097/01.HS9.0000969080.96146.ca
work_keys_str_mv AT nedumannilrithin p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia
AT batterhamemily p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia
AT weiandrew p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia
AT bajelashish p543consecutivedaydosingofhighdosecytarabineconsolidationover3daysisfeasibleinolderpatientswithacutemyeloidleukemia